000 | 01668 a2200493 4500 | ||
---|---|---|---|
005 | 20250513090509.0 | ||
264 | 0 | _c19960614 | |
008 | 199606s 0 0 eng d | ||
022 | _a0039-2499 | ||
024 | 7 |
_a10.1161/01.str.27.5.875 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBrandt, T | |
245 | 0 | 0 |
_aThrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. _h[electronic resource] |
260 |
_bStroke _cMay 1996 |
||
300 |
_a875-81 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aArterial Occlusive Diseases _xphysiopathology |
650 | 0 | 4 | _aBasilar Artery |
650 | 0 | 4 | _aCollateral Circulation |
650 | 0 | 4 | _aDisability Evaluation |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Intra-Arterial |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 |
_aIntracranial Embolism and Thrombosis _xdiagnostic imaging |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
650 | 0 | 4 | _aRegression Analysis |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aThrombolytic Therapy |
650 | 0 | 4 |
_aTissue Plasminogen Activator _xtherapeutic use |
650 | 0 | 4 | _aTomography, X-Ray Computed |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xtherapeutic use |
700 | 1 | _avon Kummer, R | |
700 | 1 | _aMüller-Küppers, M | |
700 | 1 | _aHacke, W | |
773 | 0 |
_tStroke _gvol. 27 _gno. 5 _gp. 875-81 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.str.27.5.875 _zAvailable from publisher's website |
999 |
_c8622152 _d8622152 |